Jazz Pharmaceuticals plc (JAZZ) Net margin 2016–2025
Jazz Pharmaceuticals plc (JAZZ) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.3%FY2025 · since FY2016: 26.7% → -8.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.3% | -22.1 pp |
| FY2024 | 13.8% | +2.9 pp |
| FY2023 | 10.8% | +16.9 pp |
| FY2022 | -6.1% | +4.5 pp |
| FY2021 | -10.7% | -20.7 pp |
| FY2020 | 10.1% | -14.1 pp |
| FY2019 | 24.2% | +0.6 pp |
| FY2018 | 23.6% | -6.5 pp |
| FY2017 | 30.1% | +3.5 pp |
| FY2016 | 26.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAZZ financial trends
JAZZ RevenueJAZZ Net incomeJAZZ Gross profitJAZZ Gross marginJAZZ Operating incomeJAZZ Operating marginJAZZ Operating cash flowJAZZ Free cash flowJAZZ Capital expendituresJAZZ Return on equityJAZZ Stock buybacksJAZZ Dividends paidJAZZ Total assetsJAZZ Total liabilitiesJAZZ Shareholders’ equityJAZZ overview →